Product Details for NDA 018709
CAPOZIDE 25/15 (CAPTOPRIL; HYDROCHLOROTHIAZIDE)
25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
25MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
50MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
50MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CAPTOPRIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CAPOZIDE 25/15
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018709
Product Number: 001
Approval Date: Oct 12, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
CAPOZIDE 25/25 (CAPTOPRIL; HYDROCHLOROTHIAZIDE)
Proprietary Name: CAPOZIDE 25/15
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018709
Product Number: 001
Approval Date: Oct 12, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
25MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CAPTOPRIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CAPOZIDE 25/25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018709
Product Number: 002
Approval Date: Oct 12, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
CAPOZIDE 50/15 (CAPTOPRIL; HYDROCHLOROTHIAZIDE)
Proprietary Name: CAPOZIDE 25/25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018709
Product Number: 002
Approval Date: Oct 12, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
50MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CAPTOPRIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CAPOZIDE 50/15
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018709
Product Number: 004
Approval Date: Oct 12, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
CAPOZIDE 50/25 (CAPTOPRIL; HYDROCHLOROTHIAZIDE)
Proprietary Name: CAPOZIDE 50/15
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018709
Product Number: 004
Approval Date: Oct 12, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
50MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CAPTOPRIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CAPOZIDE 50/25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018709
Product Number: 003
Approval Date: Oct 12, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CAPOZIDE 50/25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018709
Product Number: 003
Approval Date: Oct 12, 1984
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information